Recombinant IL9 (Enokizumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all IL9 (Enokizumab Biosimilar) products
- IL9 (Enokizumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This IL9 (Enokizumab Biosimilar) antibody is un-conjugated
-
Application
- ELISA
- Purpose
- Enokizumab Biosimilar - Anti-IL9 mAb
- Characteristics
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
anti-IL9 (Enokizumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Monoclonal unconjugated
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- IL9 (Enokizumab Biosimilar)
- Abstract
- IL9 (Enokizumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
-
7F3com-2H2,MEDI-528
Recombinant monoclonal antibody to IL17A. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases.
-
You are here:
